- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 114.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 136.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 123.12M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $137.11M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $679K |
| Capex | Q1 2026 · Mar 31, 2025 | $588K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $289.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $96.81M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $32.39M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $33.69M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.22B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.2B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.11B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.11B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.77B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.81B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.88B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.92B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.75 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.63 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $46.17M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $41.38M |
| Net Income | Q1 2026 · Mar 31, 2026 | $139.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | $92.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $389.28M |
| Revenue | Q1 2026 · Mar 31, 2025 | $281.59M |